Similar articles

• Antitumor vaccination: where we stand.

  Bocchia M, Bronte V, Colombo MP, De Vincentiis A, Di Nicola M, Forni G, Lanata L, Lemoli RM, Massaia M, Rondelli D, Zanon P, Tura S. Bocchia M, et al. Haematologica. 2000 Nov;85(11):1172-206. Haematologica. 2000. PMID: 11074658 Review.
• Vaccination with liposome--DNA complexes elicits enhanced antitumor immunity.

  U'Ren L, Kedl R, Dow S. U'Ren L, et al. Cancer Gene Ther. 2006 Nov;13(11):1033-44. doi: 10.1038/sj.cgt.7700982. Epub 2006 Jul 14. Cancer Gene Ther. 2006. PMID: 16841080
• Local tumor irradiation augments the antitumor effect of cytokine-producing autologous cancer cell vaccines in a murine glioma model.

  Lumniczky K, Desaknai S, Mangel L, Szende B, Hamada H, Hidvegi EJ, Safrany G. Lumniczky K, et al. Cancer Gene Ther. 2002 Jan;9(1):44-52. doi: 10.1038/sj.cgt.7700398. Cancer Gene Ther. 2002. PMID: 11916244
• Idiotypic vaccination for B-cell malignancies as a model for therapeutic cancer vaccines: from prototype protein to second generation vaccines.

  Ruffini PA, Neelapu SS, Kwak LW, Biragyn A. Ruffini PA, et al. Haematologica. 2002 Sep;87(9):989-1001. Haematologica. 2002. PMID: 12217812 Review.
• Vaccine therapy of established tumors in the absence of autoimmunity.

  Hodge JW, Grosenbach DW, Aarts WM, Poole DJ, Schlom J. Hodge JW, et al. Clin Cancer Res. 2003 May;9(5):1837-49. Clin Cancer Res. 2003. PMID: 12738742